Recent Updates — BFLYW

Butterfly Network, Inc. reported that Dr. Erica Schwartz resigned from its Board of Directors effective August 5, 2026, upon her Senate confirmation as Director of the Centers for Disease Control and Prevention (CDC). The resignation was not due to any disagreement with the Company regarding operations or policies. Butterfly Network operates in the medical technology industry, developing semiconductor-based ultrasound devices, cloud software, and AI solutions.

Butterfly Network reported second quarter 2026 results with revenue of $32.6 million, a 39% year-over-year increase driven by Embedded partnerships and probe sales. Gross margin expanded to 71.4%, while the net loss narrowed to $12.9 million and adjusted EBITDA loss improved to $1.4 million. The company raised its full-year revenue guidance to $119–$123 million and adjusted EBITDA loss guidance to $19–$23 million, citing strong enterprise software momentum and FedRAMP progress. Butterfly operates in the medical technology industry, specializing in semiconductor-based ultrasound devices, cloud software, and AI solutions.